Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapy

This publication has 60 references indexed in Scilit:

• Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease
  Journal of the American College of Cardiology, 2004
• Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
  JAMA, 2003
• From Vulnerable Plaque to Vulnerable Patient
  Circulation, 2003
• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial
  The American Journal of Cardiology, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
  New England Journal of Medicine, 1999
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Prevalence of risk factors in men with premature coronary artery disease
  The American Journal of Cardiology, 1991
• Early incorporation of cell-derived cholesterol into pre-.beta.-migrating high-density lipoprotein
  Biochemistry, 1988